Food labeling: health claims and labeling statements; dietary fiber and cancer; antioxidant vitamins and cancer; omega-3 fatty acids and coronary heart disease; folate and neural tube defects; revocation. Food and Drug Administration, HHS.  Final rule.
The Food and Drug Administration (FDA) is revoking its regulations codifying the agency's decision not to authorize the use of health claims for four substance-disease relationships in the labeling of foods, including dietary supplements: Dietary fiber and cancer, antioxidant vitamins and cancer, omega-3 fatty acids and coronary heart disease, and the claim that 0.8 milligram (mg) of folate in dietary supplement form is more effective in reducing the risk of neural tube defects than a lower amount in conventional food.  This action is being taken in response to a decision of the U.S. Court of Appeals for the D.C. Circuit invalidating these regulations and directing FDA to reconsider whether to authorize the four health claims.  This action will result in the removal of the regulations but does not constitute FDA authorization of the four claims.  FDA is completing its reconsideration of the claims and expects to issue decisions on all four claims by October 10, 2000.
D000975:Antioxidants; D004043:Dietary Fiber / Q000627:therapeutic use; D019587:Dietary Supplements; D015525:Fatty Acids, Omega-3; D005492:Folic Acid; D005515:Food Labeling / Q000331:legislation & jurisprudence*; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009436:Neural Tube Defects / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D000975:Antioxidants; D004043:Dietary Fiber; D015525:Fatty Acids, Omega-3; D005492:Folic Acid